Short-term consequences of N-methyl-D-aspartate excitotoxicity in rat magnocellular nucleus basalis: Effects on in vivo labelling of cholinergic neurons

Neuroscience

Volumn 108, Issue 4, 2001, Pages 611-627

  Harkany, T ^a   Grosche, J ^b   Mulder, J ^a   Horvath, K M ^a   Keijser, J ^a   Hortobagyi T ^c   Luiten, P G M ^a   Hartig W ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Basal forebrain; Carbocyanine 3 conjugated immunoglobulin 192; Cholinergic system; Neurodegeneration; p75 low affinity neurotrophin receptor; Recovery

Indexed keywords

ACETYLCHOLINE; AMINO ACID RECEPTOR STIMULATING AGENT; CARBOCYANINE; CHOLINE ACETYLTRANSFERASE; CYANINE DYE 3; FLUORESCENT DYE; FLUORO JADE; IMMUNOGLOBULIN G; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYLASPARTIC ACID; NERVE GROWTH FACTOR RECEPTOR; NEUROTOXIN; NMDA RECEPTOR 2A; NMDA RECEPTOR 2B; RECEPTORS, N METHYL D ASPARTATE;

ANIMAL; ARTICLE; CHEMISTRY; CONFOCAL MICROSCOPY; DRUG EFFECT; ENZYMOLOGY; GLIA; IATROGENIC DISEASE; IMMUNOHISTOCHEMISTRY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; METABOLISM; METHODOLOGY; MEYNERT BASAL NUCLEUS; NERVE CELL; NERVE DEGENERATION; NERVE TRACT; PATHOLOGY; PHYSIOLOGY; RAT; RAT STRAIN; SENSITIVITY AND SPECIFICITY;

ACETYLCHOLINE; ANIMAL; BASAL NUCLEUS OF MEYNERT; CARBOCYANINES; CHOLINE O-ACETYLTRANSFERASE; EXCITATORY AMINO ACID AGONISTS; FLUORESCENT DYES; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAVENTRICULAR; MALE; MICROSCOPY, CONFOCAL; N-METHYLASPARTATE; NERVE DEGENERATION; NEURAL PATHWAYS; NEUROGLIA; NEURONS; NEUROTOXINS; RATS; RATS, WISTAR; RECEPTOR, NERVE GROWTH FACTOR; RECEPTORS, N-METHYL-D-ASPARTATE; SENSITIVITY AND SPECIFICITY; SUPPORT, NON-U.S. GOV'T;

EID: 0035232783     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(01)00443-2     Document Type: Article

References (73)

1. Alreja, M., Wu, M., Liu, W., Atkins, J.B., Leranth, C., Shanabrough, M., 2000. Muscarinic tone sustains impulse flow in the septohippocampal GABA but not cholinergic pathway: implications for learning and memory. J. Neurosci. 20, 8103-8110.
2. Anguelova, E., Boularand, S., Nowicki, J.-P., Benavides, J., Smirnova, T., 2000. Up-regulation of genes involved in cellular stress and apoptosis in a rat model of hippocampal degeneration. J. Neurosci. Res. 59, 209-217.
3. Arendt, T., Bigl, V., Tennstedt, A., Arendt, A., 1985. Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease. Neuroscience 14, 1-14.
4. Bartus, R.T., Dean, R.L., Beer, B., Lippa, A.S., 1982. The cholinergic hypothesis of geriatric memory dysfunction. Science 217, 408-414.
5. Benedetti, M., Levi, A., Chao, M.V., 1993. Differential expression of nerve growth factor receptors leads to altered binding affinity and neurotrophin responsiveness. Proc. Natl. Acad. Sci. USA 90, 7859-7863.
6. Bickler, P.E., Donohoe, P.H., Buck, L.T., 2000. Hypoxia-induced silencing of NMDA receptors in turtle neurons. J. Neurosci. 20, 3522-3528.
7. Bonfoco, E., Krainc, D., Ankarcrona, M., Nicotera, P., Lipton, S.A., 1995. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. USA 92, 7162-7166.
8. Boyes, B.E., Kim, S.U., Lee, V., Sung, S.C., 1986. Immunohistochemical co-localization of S-100β and the glial fibrillary acidic protein in rat brain. Neuroscience 17, 857-865.
9. Chandler, C.E., Parsons, L.M., Hosang, M., Shooter, E.M., 1984. A monoclonal antibody modulates the interaction of nerve growth factor with PC12 cells. J. Biol. Chem. 259, 6882-6889.
10. Ciccarelli, R., Di Iorio, P., Bruno, V., Battaglia, G., D'Alimonte, I., D'Onofrio, M., Nicoletti, F., Caciagli, F., 1999. Activation of A(1) adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100β protein from cultured astrocytes. Glia 27, 275-281.
11. NTR. Curr. Opin. Neurobiol. 7, 413-418.
12. Détâri, L., Rasmusson, D.D., Semba, K., 1999. The role of basal forebrain neurons in tonic and phasic activation of the cerebral cortex. Prog. Neurobiol. 58, 249-277.
13. Doble, A., 1999. The role of excitotoxicity in neurodegenerative disease: Implications for therapy. Pharmacol. Ther. 81, 163-221.
14. Dobrowsky, R.T., Werner, M.H., Castellino, A.M., Chao, M.V., Hannun, Y.A., 1994. Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science 265, 1596-1599.
15. Duchen, M.R., 2000. Mitochondria and calcium: from cell signalling to cell death. J. Physiol. (Lond.) 529.1, 57-68.
16. Friedman, B., Hockfield, S., Black, J.A., Woodruff, K.A., Waxman, S.G., 1989. In situ demonstration of mature oligodendrocytes and their processes: an immunocytochemical study with a new monoclonal antibody, rip. Glia 2, 380-390.
17. Gallagher, M., Colombo, P.J., 1995. Ageing: the cholinergic hypothesis of cognitive decline. Curr. Opin. Neurobiol. 5, 161-168.
18. Giovannelli, L., Veltri, M., Casamenti, F., Pepeu, G., 2000. NGF treatment potentiates c-fos expression in the rat nucleus basalis upon excitotoxic lesion with quisqualic acid. Brain Res. 853, 136-141.
19. Glazner, G.W., Chan, S.L., Lu, C., Mattson, M.P., 2000. Caspase-mediated degradation of AMPA receptor subunits: a mechanism for preventing excitotoxic necrosis and ensuring apoptosis. J. Neurosci. 20, 3641-3649.
20. Harkany, T., Ábrahám, I., Kónya, C., Nyakas, C., Zarándi, M., Penke, B., Luiten, P.G.M., 2000a. Mechanisms of β-amyloid neurotoxicity: perspectives of pharmacotherapy. Rev. Neurosci. 11, 329-382.
21. 2+ antagonist nimodipine. Neuroscience 101, 101-114.
22. NTR in the rat basal forebrain. Brain Res. 808, 155-165.
23. Heckers, S., Ohtake, T., Wiley, R.G., Lappi, D.A., Geula, C., Mesulam, M.M., 1994. Complete and selective cholinergic denervation of rat neocortex and hippocampus but not amygdala by an immunotoxin against the p75 NGF receptor. J. Neurosci. 14, 1271-1289.
24. Hedreen, J.C., Bacon, S.J., Price, D.L., 1985. A modified histochemical technique to visualize acetylcholinesterase-containing axons. J. Histochem. Cytochem. 33, 133-140.
25. Horvath, K.M., Ábrahám, I., Harkany, T., Meerlo, P., Bohus, B.G.J., Nyakas, C., Luiten, P.G.M., 2000. Postnatal treatment with ACTH4-9 analog ORG2766 attenuates NMDA-induced excitotoxicity in rat nucleus basalis in adulthood. Eur. J. Pharmacol. 405, 33-42.
26. Horvath, K.M., Härtig, W., Van der Veen, R., Keijser, J., Mulder, J., Ziegert, M., Van der Zee, E.A., Harkany, T., Luiten, P.G.M., 2001. 17β-Estradiol enhances cortical cholinergic innervation and preserves synaptic density following excitotoxic lesions to the rat nucleus basalis magnocellularis. Neuroscience, in press.
27. Iraizoz, I., Guijarro, J.L., Gonzalo, L.M., de Lacalle, S., 1999. Neuropathological changes in the nucleus basalis correlate with clinical measures of dementia. Acta Neuropathol. 98, 186-196.
28. Johnson, E.M., Taniuchi, M., Clark, H.B., Springer, J.E., Koh, S., Tayrien, M.W., Loy, R., 1987. Demonstration of the retrograde transport of nerve growth factor receptor in the peripheral and central nervous system. J. Neurosci. 7, 923-929.
29. Kacza, J., Grosche, J., Seeger, J., Brauer, K., Brückner, G., Härtig, W., 2000. Laser scanning and electron microscopic evidence for the rapid and specific in vivo labelling of cholinergic neurons in the rat basal forebrain with fluorochromated antibodies. Brain Res. 867, 232-238.
30. Kása, P., Rakonczay, Z., Gulya, K., 1997. The cholinergic system in Alzheimer's disease. Prog. Neurobiol. 52, 511-535.
31. Kobayashi, S., Millhorn, D.E., 2000. Regulation of N-methyl-D-aspartate receptor expression and N-methyl-D-aspartate-induced cellular response during chronic hypoxia in differentiated rat PC12 cells. Neuroscience 101, 1153-1162.
32. Kordower, J.H., Bartus, R.T., Bothwell, M., Schatteman, G., Gash, D.M., 1988. Nerve growth factor receptor immunoreactivity in the nonhuman primate (Cebus apella): distribution, morphology, and colocalization with cholinergic enzymes. J. Comp. Neurol. 277, 465-486.
33. Kume, T., Nishikawa, H., Tomioka, H., Katsuki, H., Akaike, A., Kaneko, S., Maeda, T., Kihara, T., Shimohama, S., 2000. p75-mediated neuroprotection by NGF against glutamate cytotoxicity in cortical cultures. Brain Res. 852, 279-289.
34. Kwok, K.H.K., Law, K.B., Wong, R.N.S., Yung, K.K.L., 1999. Immunolesioning of nerve growth factor p75 receptor-containing neurons in the rat brain by a novel immunotoxin: anti-p75-anti-mouse IgG-trichosanthin conjugates. Brain Res. 846, 154-163.
35. Lee, J.M., Zipfel, G.J., Choi, D.W., 1999. The changing landscape of ischaemic brain injury mechanisms. Nature 399, A7-A14.
36. Li, Z.S., Furness, J.B., 1998. Immunohistochemical localisation of cholinergic markers in putative intrinsic primary afferent neurons of the guinea-pig small intestine. Cell Tissue Res. 294, 35-43.
37. Lipton, P., 1999. Ischemic cell death in brain neurons. Physiol. Rev. 79, 1431-1568.
38. Luetjens, C.M., Bui, N.T., Sengpiel, B., Münstermann, G., Poppe, M., Krohn, A.J., Bauerbach, E., Krieglstein, J., Prehn, J.H.M., 2000. Delayed mitochondrial dysfunction in excitotoxic neuron death: cytochrome c release and a secondary increase in superoxide production. J. Neurosci. 20, 5715-5723.
39. Luiten, P.G.M., Gaykema, R.P., Traber, J., Spencer, D.G., 1987. Cortical projection patterns of magnocellular basal nucleus subdivisions as revealed by anterogradely transported Phaseolus vulgaris leucoagglutinin. Brain Res. 413, 229-250.
40. 2+ antagonist nimodipine. Influence of aging and developmental drug treatment. Neurodegeneration 4, 307-314.
41. Mattson, M.P., LaFerla, F.M., Chan, S.L., Leissring, M.A., Shepel, P.N., Geiger, J.D., 2000. Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 23, 222-229.
42. Mesulam, M.M., 1995. The cholinergic contribution to neuromodulation in the cerebral cortex. Semin. Neurosci. 7, 297-307.
43. Mesulam, M.M., Mufson, E.J., Wainer, B.J., Levey, A.I., 1983. Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience 10, 1185-1201.
44. Mufson, E.J., Bothwell, M., Hersh, L.B., Kordower, J.H., 1989. Nerve growth factor receptor immunoreactive profiles in the normal, aged human basal forebrain: colocalization with cholinergic neurons. J. Comp. Neurol. 285, 196-217.
45. Mufson, E.J., Kroin, J.S., Sendera, T.J., Sobreviela, T., 1999. Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases. Prog. Neurobiol. 57, 451-484.
46. Nath, R., Scott, M., Nadimpalli, R., Gupta, R., Wang, K.K.W., 2000. Activation of apoptosis-linked caspase(s) in NMDA-injured brains in neonatal rats. Neurochem. Int. 36, 119-126.
47. Nicholls, D.G., Budd, S.L., Ward, M.W., Castilho, R.F., 1999. Excitotoxicity and mitochondria. Biochem. Soc. Symp. 66, 55-67.
48. Oh, J.D., Chartisathian, K., Chase, T.N., Butcher, L.L., 2000. Overexpression of neurotrophin receptor p75 contributes to the excitotoxin-induced cholinergic neuronal death in rat basal forebrain. Brain Res. 853, 174-185.
49. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates, 2nd edn. Academic Press, Sydney.
50. Perez-Navarro, E., Arenas, E., Reiriz, J., Calvo, N., Alberch, J., 1996. Glial cell line-derived neurotrophic factor protects striatal calbindin-immunoreactive neurons from excitotoxic damage. Neuroscience 75, 345-352.
51. Petralia, R.S., Wang, Y.-X., Wenthold, R.J., 1994. The NMDA receptor subunits NR2A and NR2B show histological and structural localization patterns similar to those of NR1. J. Neurosci. 14, 6102-6120.
52. Robinson, A.P., White, T.M., Mason, D.W., 1986. Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3. Immunology 57, 239-247.
53. Rossner, S., 1997. Cholinergic immunolesions by 192IgG-saporin - useful tool to simulate pathogenic aspects of Alzheimer's disease. Int. J. Dev. Neurosci. 15, 835-850.
54. Savaskan, N.E., Eyüpoglu, I.Y., Bräuer, A.U., Plaschke, M., Ninnemann, O., Nitsch, R., Skutella, T., 2000. Entorhinal cortex lesion studied with the novel dye fluoro-jade. Brain Res. 864, 44-51.
55. Scali, C., Prosperi, C., Vannucchi, M.G., Pepeu, G., Casamenti, F., 2000. Brain inflammatory reaction in an animal model of neuronal degeneration and its modulation by an anti-inflammatory drug: implication in Alzheimer's disease. Eur. J. Neurosci. 12, 1900-1912.
56. Schmued, L.C., Albertson, C., Slikker, W., Jr., 1997. Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res. 751, 37-46.
57. Selkoe, D.J., 1999. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399, A23-A31.
58. Semba, K., 2000. Multiple output pathways of the basal forebrain: organization, chemical heterogenity, and roles in vigilance. Behav. Brain Res. 115, 117-141.
59. Smith, M.L., Deadwyler, S.A., Booze, R.M., 1993. 3-D reconstruction of the cholinergic basal forebrain system in young and aged rats. Neurobiol. Aging 14, 389-392.
60. Sobreviela, T., Clary, D.O., Reichardt, L.F., Brandabur, M.M., Kordower, J.H., Mufson, E.J., 1994. TrkA-immunoreactive profiles in the central nervous system: colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin. J. Comp. Neurol. 350, 587-611.
61. Standaert, D.G., Friberg, I.K., Landwehrmeyer, G.B., Young, A.B., Penney, J.B., 1999. Expression of NMDA glutamate receptor subunit mRNAs in neurochemically identified projection and interneurons in the striatum of the rat. Mol. Brain Res. 64, 11-23.
62. Szutowicz, A., Tomaszewicz, M., Jankowska, A., Madziar, B., Bielarczyk, H., 2000. Acetyl-CoA metabolism in cholinergic neurons and their susceptibility to neurotoxic inputs. Metab. Brain Dis. 15, 29-44.
63. Thompson, R.J., Doran, J.F., Jackson, P., Dhillon, A.P., Rode, J., 1983. PGP 9.5 - a new marker for vertebrate neurons and neuroendocrine cells. Brain Res. 278, 224-228.
64. Tremere, L.A., Pinaud, R., Grosche, J., Härtig, W., Rasmusson, D.D., 2000. Antibody for human p75 LNTR identifies cholinergic basal forebrain of non-primate species. NeuroReport 11, 2177-2183.
65. Tuszynski, M.H., 2000. Intraparenchymal NGF infusions rescue degenerating cholinergic neurons. Cell. Transplant. 9, 629-636.
66. Vanderklish, P.W., Bahr, B.A., 2000. The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states. Int. J. Exp. Pathol. 81, 323-339.
67. Wang, H., Zhang, R.X., Wang, R., Qiao, J.T., 1999. Decreased expression of N-methyl-D-aspartate (NMDA) receptors in rat dorsal root ganglion following complete Freund's adjuvant-induced inflammation: an immunocytochemical study for NMDA NR1 subunit. Neurosci. Lett. 265, 195-198.
68. Wenk, G.L., Willard, L.B., 1998. The neural mechanisms underlying cholinergic cell death within the basal forebrain. Int. J. Dev. Neurosci. 16, 729-735.
69. Wenk, G.L., Harrington, C.A., Tucker, D.A., Rance, N.E., Walker, L.C., 1992. Basal forebrain neurons and memory: a biochemical, histological, and behavioral study of differential vulnerability to ibotenate and quisqualate. Behav. Neurosci. 106, 909-923.
70. West, M.J., 1993. New stereological methods for counting neurons. Neurobiol. Aging 14, 275-285.
71. Wiley, R.G., 1992. Neural lesioning with ribosome-inactivating proteins: suicide transport and immunolesioning. Trends Neurosci. 15, 285-290.
72. Willard, L.B., Hauss-Wegrzyniak, B., Wenk, G.L., 1999. Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats. Neuroscience 88, 193-200.
73. Wu, M., Shanabrough, M., Leranth, C., Alreja, M., 2000. Cholinergic excitation of septohippocampal GABA but not cholinergic neurons: implications for learning and memory. J. Neurosci. 20, 3900-3908.